Article Details

Grifols ponies up $80M for polyclonal antibody biotech GigaGen

Retrieved on: 2021-03-10 15:00:00

Tags for this article:

Click the tags to see associated articles and topics

Grifols ponies up $80M for polyclonal antibody biotech GigaGen. View article details on hiswai:

Excerpt

It is also developing recombinant monoclonal antibody treatments for various cancer targets including CTLA-4, PD-L1 and TGF-beta. The programs ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up